Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

NCT00457808 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Tuberous Sclerosis
Lymphangioleiomyomatosis

Interventions

DRUG: Rapamycin, sirolimus

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]
[object Object]